張 宜崴

Medicine & Life Sciences

1. Survival 100%
2. Neoplasms 94%
3. Rectal Neoplasms 86%
4. Chemoradiotherapy 81%
5. Urinary Tract 81%
6. Carcinoma 68%
7. Neoplasm Metastasis 65%
8. Radiofrequency Ablation 65%
9. Urinary Bladder 61%
10. Nasopharyngeal Carcinoma 56%
11. Epithelial Cells 52%
12. Recurrence 40%
13. Data Mining 28%
14. Endoscopic Mucosal Resection 26%
15. Protein Methyltransferases 25%
16. Genes 24%
17. Esophageal Squamous Cell Carcinoma 23%
18. Proteins 23%
19. Non-alcoholic Fatty Liver Disease 21%
20. Renal Cell Carcinoma 21%
21. Biomarkers 20%
22. Immunohistochemistry 20%
23. Therapeutics 20%
24. thrombospondin 2 20%
25. Methyltransferases 20%
26. Esophageal Neoplasms 19%
27. Up-Regulation 19%
28. intestinal peptide-proton cotransporter 18%
29. O(6)-Methylguanine-DNA Methyltransferase 18%
30. necdin 18%
31. DNA 17%
32. glutamate decarboxylase 1 17%
33. branched-chain-amino-acid transaminase 17%
34. Multivariate Analysis 17%
35. EphA1 Receptor 16%
36. Tenofovir 16%
37. Complement C1 15%
38. O-(6)-methylguanine 15%
39. Craniospinal Irradiation 15%
40. Hyaluronan Synthases 15%
41. Gliosarcoma 15%
42. Clear Cell Adenocarcinoma 15%
43. Endothelin-Converting Enzymes 15%
44. Acinetobacter Infections 15%
45. Ganglioglioma 14%
46. Interleukin-2 Receptor alpha Subunit 14%
47. Hematoma, Subdural, Acute 14%
48. Dual Oxidases 14%
49. Fused Kidney 14%